Cargando…

Identifying and Validating a Combined mRNA and MicroRNA Signature in Response to Imatinib Treatment in a Chronic Myeloid Leukemia Cell Line

Imatinib, a targeted tyrosine kinase inhibitor, is the gold standard for managing chronic myeloid leukemia (CML). Despite its wide application, imatinib resistance occurs in 20–30% of individuals with CML. Multiple potential biomarkers have been identified to predict imatinib response; however, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhutra, Steven, Lenkala, Divya, LaCroix, Bonnie, Ye, Meng, Huang, R. Stephanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266614/ https://www.ncbi.nlm.nih.gov/pubmed/25506832 http://dx.doi.org/10.1371/journal.pone.0115003

Ejemplares similares

MicroRNA-181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib
por: WANG, GUANGYU, et al.
Publicado: (2015)

Investigating the microRNA-mRNA regulatory network in acute myeloid leukemia
por: Zhang, Haiguo, et al.
Publicado: (2017)

LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21
por: Zhou, Xiangyu, et al.
Publicado: (2017)

MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations
por: San José-Enériz, Edurne, et al.
Publicado: (2009)

microRNA expression signatures of gastrointestinal stromal tumours: associations with imatinib resistance and patient outcome
por: Akçakaya, P, et al.
Publicado: (2014)

ABCB1 and BMI1 mRNA expression in patients with chronic myeloid leukemia: impact on imatinib efficacy
por: Bedewy, Ahmed M. L., et al.
Publicado: (2019)

Molecular Response to Imatinib and Its Correlation with mRNA Expression Levels of Imatinib Influx Transporter (OCT1) in Indian Chronic Myeloid Leukemia Patients
por: Chhikara, S, et al.
Publicado: (2017)

An Integrated mRNA and microRNA Expression Signature for Glioblastoma Multiforme Prognosis
por: Xiong, Jie, et al.
Publicado: (2014)

MicroRNA and mRNA Signatures in Ischemia Reperfusion Injury in Heart Transplantation
Publicado: (2014)

MicroRNA and mRNA Signatures in Ischemia Reperfusion Injury in Heart Transplantation
por: Zhou, Liangyi, et al.
Publicado: (2013)

Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding
por: Dzikiewicz-Krawczyk, Agnieszka, et al.
Publicado: (2014)

Decreased expression of microRNA-214 contributes to imatinib mesylate resistance of chronic myeloid leukemia patients by upregulating ABCB1 gene expression
por: Jin, Jing, et al.
Publicado: (2018)

MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies
por: Setijono, Stephanie Rebecca, et al.
Publicado: (2018)

MicroRNA-10a/b are regulators of myeloid differentiation and acute myeloid leukemia
por: Bi, Laixi, et al.
Publicado: (2018)

Overexpression of primary microRNA 221/222 in acute myeloid leukemia
por: Rommer, Anna, et al.
Publicado: (2013)

Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia
por: Cheng, Zhiheng, et al.
Publicado: (2021)

MicroRNA networks in FLT3-ITD acute myeloid leukemia
por: Hoang, Dinh Hoa, et al.
Publicado: (2022)

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
por: Wei, Guoqing, et al.
Publicado: (2010)

An integrated lncRNA, microRNA and mRNA signature to improve prognosis prediction of colorectal cancer
por: Xiong, Yongfu, et al.
Publicado: (2017)

Imatinib in Chronic Myeloid Leukemia: an Overview
por: Sacha, Tomasz
Publicado: (2014)

MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells
por: Lin, Tsung-Yao, et al.
Publicado: (2016)

Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
por: Cascione, Luciano, et al.
Publicado: (2013)

Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer
por: Lopacinska-Jørgensen, Joanna, et al.
Publicado: (2021)

Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines
por: Bilajac, Esma, et al.
Publicado: (2022)

Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivity
por: LaCroix, Bonnie, et al.
Publicado: (2014)

Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia
por: Guo, Yingmeng
Publicado: (2019)

Identification and validation of potential mRNA- microRNA- long-noncoding RNA (mRNA-miRNA-lncRNA) prognostic signature for cervical cancer
por: Wang, Jie, et al.
Publicado: (2021)

Pathogenic microRNA’s in myeloid malignancies
por: Khalaj, Mona, et al.
Publicado: (2014)

Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines
por: Lompardía, Silvina, et al.
Publicado: (2019)

Numerical modelling of microRNA-mediated mRNA decay identifies novel mechanism of microRNA controlled mRNA downregulation
por: Vohradsky, Jiri, et al.
Publicado: (2010)

Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely
por: Ohyashiki, Junko H, et al.
Publicado: (2014)

Correction: MicroRNA-1301-Mediated RanGAP1 Downregulation Induces BCR-ABL Nuclear Entrapment to Enhance Imatinib Efficacy in Chronic Myeloid Leukemia Cells
por: Lin, Tsung-Yao, et al.
Publicado: (2017)

Prognostic alternative mRNA splicing signatures and associated splicing factors in acute myeloid leukemia
por: Jin, Peng, et al.
Publicado: (2020)

Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients
por: Morrison, Gladys, et al.
Publicado: (2016)

Integration of SNP and mRNA Arrays with MicroRNA Profiling Reveals That MiR-370 Is Upregulated and Targets NF1 in Acute Myeloid Leukemia
por: García-Ortí, Laura, et al.
Publicado: (2012)

Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets
por: Jin, Daeyong, et al.
Publicado: (2016)

Imatinib in chronic myeloid leukemia elderly patients
por: Gugliotta, Gabriele, et al.
Publicado: (2011)

Integrative approaches for analysis of mRNA and microRNA high-throughput data
por: Nazarov, Petr V., et al.
Publicado: (2021)

MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide
por: Wang, Zhiguo, et al.
Publicado: (2019)

Dynamic patterns of microRNA expression during acute myeloid leukemia state-transition
por: Frankhouser, David E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9dp80nnh3nldkr5uig5s6od44p